Inhibition of the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) as a novel approach to type 2 diabetes treatment.

被引：0
|
作者：
Barf, T
Vallgårda, J
Kurz, G
Alberts, P
Abrahmsen, L
机构：
[1] Biovitrum, Dept Med Chem, SE-75137 Uppsala, Sweden
[2] Biovitrum, Dept Struct Chem, SE-75137 Uppsala, Sweden
[3] Biovitrum, Dept Biol, SE-75137 Uppsala, Sweden
[4] Biovitrum, Dept Assay Dev & Screening, SE-75137 Uppsala, Sweden
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
188-MEDI
引用
收藏
页码：U207 / U207
页数：1
相关论文
共 50 条
  • [31] 11β-hydroxysteroid dehydrogenase type 1 (11-HSD-1) activities in patients with hypopituitarism
    Kobayashi, Y
    Tagawa, N
    Ikariko, N
    Imamura, T
    Higashide, T
    Mori, H
    Inada, H
    Yamano, T
    CLINICAL CHEMISTRY, 2005, 51 : A226 - A226
  • [32] Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Expression in Human Airway Smooth Muscle (HASM) Cells.
    Grumbach, Y.
    Hu, A.
    Grunstein, J. S.
    Nino, G.
    Gober, L.
    Grunstein, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [33] An association study of 11B hydroxysteroid dehydrogenase type 1 (11HSD1) polymorphisms in Samoans with type 2 diabetes and obesity
    Musaad, S
    Indugula, SR
    Kaushal, R
    McGarvey, ST
    Tufa, J
    Viali, S
    Weeks, DE
    Deka, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S25 - S25
  • [34] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
    Deborah J. Wake
    Brian R. Walker
    Endocrine, 2006, 29 : 101 - 108
  • [35] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
    Wake, DJ
    Walker, BR
    ENDOCRINE, 2006, 29 (01) : 101 - 108
  • [36] Identification and optimisation of 3,3-dimethylazetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1)
    McCoull, William
    Augustin, Martin
    Blake, Caroline
    Ertan, Anne
    Kilgour, Elaine
    Krapp, Stephan
    Moore, Jane E.
    Newcombe, Nicholas J.
    Packer, Martin J.
    Rees, Amanda
    Revill, John
    Scott, James S.
    Selmi, Nidhal
    Gerhardt, Stefan
    Ogg, Derek J.
    Steinbacher, Stefan
    Whittamore, Paul R. O.
    MEDCHEMCOMM, 2014, 5 (01) : 57 - 63
  • [37] Oxysterols attenuate the stimulatory effects of TNFα on 11 hydroxysteroid dehydrogenase type 1 (11βHSD1) activity in human adipose stromal cells
    Khalil, W
    Lee, K
    Lim, H
    Smith, N
    Richards, R
    Yang, K
    Killinger, D
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 515 - 521
  • [38] S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Zhang, Rihua
    Kan, Jing Bao
    Lu, Shan
    Tong, Pei
    Yang, Jie
    Xi, Ling
    Liang, Xiubing
    Su, Dongming
    Li, Dong
    Liu, Yun
    BIOSCIENCE REPORTS, 2019, 39
  • [39] Reduction of acyl glucuronidation in a series of acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors: the discovery of AZD6925
    Scott, James S.
    Barton, Peter
    Bennett, Stuart N. L.
    deSchoolmeester, Joanne
    Godfrey, Linda
    Kilgour, Elaine
    Mayers, Rachel M.
    Packer, Martin J.
    Rees, Amanda
    Schofield, Paul
    Selmi, Nidhal
    Swales, John G.
    Whittamore, Paul R. O.
    MEDCHEMCOMM, 2012, 3 (10) : 1264 - 1269
  • [40] Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11β - hydroxysteroid Dehydrogenase Type 1 (11β-HSD1): Virtual Screening and Docking Results
    Ziolkovskiy, Dmitry V.
    Lipson, Victoria V.
    Nikitina, Anastasia D.
    Chebanov, Valentin A.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (03) : 226 - 233
12345